Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Friday, 21 April 2017

Weifa ASA: Invitation to presentation of Weifa's Q1 2017 results, Thursday 27 April

Weifa ASA    

Published: 10:51 CEST 21-04-2017 /GlobeNewswire /Source: Weifa ASA / : WEIFA /ISIN: NO0010308240

Weifa ASA: Invitation to presentation of Weifa's Q1 2017 results, Thursday 27 April

Oslo, 21 April 2017

 

Weifa ASA (OSE: WEIFA), Norway's leading consumer health company, will release its first quarter 2017 results on Thursday 27 April 2017.

 

The results will be presented by Weifa's CEO Kathrine Gamborg Andreassen and CFO Simen Nyberg-Hansen at 08:30 CET at Felix Konferansesenter, Bryggetorget 3, Oslo, Norway. Following the presentation, there will be a Q&A session. The presentation will be held in English.

 

The presentation will also be webcast live and can be accessed directly from http://webtv.hegnar.no/presentation.php?webcastId=51528850or http://www.weifa.no/webcast.Questions may be submitted live during the presentation.

 

The quarterly report and the presentation materials will be available on www.weifa.com/Investor/ and www.newsweb.no, as well as on news wires.

 

Weifa welcomes all interested parties.

 

For further information, please contact:

 

Simen Nyberg-Hansen

CFO

+47 9820 6355

simen.nyberg-hansen@weifa.no

 

 

Weifa is Norway's leading consumer health company. We supply real value through medicines, lifestyle products and solutions that address the essential needs of consumers, customers and professional partners. Weifa was founded in 1940 and now employs about 30 highly qualified people at our headquarters in Oslo. The company has a strong position in Norway and is the market leader in pain relief, with well-established brands such as Paracet and Ibux. We are also present in other key areas such as dietary supplements and treatment for colds and respiratory problems. Weifa is listed on the Oslo Børs (ticker WEIFA). For further information, please visit: www.weifa.no





This announcement is distributed by Nasdaq Corporate Solutions (One Liberty Plaza, 165 Broadway, New York, NY 10006. Tel: +1 212 401 8700. www.nasdaqomx.com) on behalf of NASDAQ OMX Corporate Solutions clients. Source: Weifa ASA, Postboks 6733 Etterstad, Oslo NO-0609, Norge
If you would like to unsubscribe and stop receiving these e-mails click here.